DIURETIC EFFECT OF BREMAZOCINE, A KAPPA-OPIOID WITH CENTRAL AND PERIPHERAL SITES OF ACTION

Simple item page
dc.contributor.authorSALAS, SP
dc.contributor.authorROBLERO, J
dc.contributor.authorURETA, H
dc.contributor.authorHUIDOBROTORO, JP
dc.date.accessioned2025-01-23T19:23:42Z
dc.date.available2025-01-23T19:23:42Z
dc.date.issued1989
dc.description.abstractIntracerebroventricular or i.p. injections of bremazocine produced a dose-dependent diuretic response and increased glomerular filtration rate in hydrated as well as in nonhydrated rats. The potency and magnitude of the bremazocine-induced diuresis were more pronounced in the nonhydrated group of rats. That bremazocine has a central component of action is deduced from the fact that 0.1 .mu.g of the opioid administered centrally caused a significant increase in urine output; proportionally, larger doses of bremazocine were required to produce the same diuretic effect when the drug was administered parenterally. Bremazocine did not change the total amount of urinary Na+ and K+ as compared to the saline controls; it increased significantly the free water clearance. The bremazocine-induced diuresis was antagonized in a competitive fashion by 10 mg/kg of naloxone giving further support to the notion that the mechanism of action of bremazocine involves activation of kappa-opioid receptors. Bremazocine injected i.v. to nonanesthetized rats increased mean systemic blood pressure in a dose-dependent manner; the pressor action of the opiate was blocked and prevented by 1 mg/kg of naloxone. In contrast, i.c.v. administration of bremazocine did not change mean systemic blood pressure but produced a dose-related increase in urine output. To determine whether in addition to a central site bremazocine also activates a renal mechanism, experiments were performed in the isolated perfused rat kidney. Bremazocine (0.15-2.5 .mu.M) caused a dose-dependent diurectic response and a significant rise in the perfusion pressure as well as in glomerular filtration rate. In contrast to the whole animal studies, in vitro administration of bremazocine resulted in a marked natriuresis and kaliuresis proportional to the dose. The renal effects were antagonized by naloxone, suggesting the existence of a local opiate renal mechanism. In conclusion, the present results demonstrate that in addition to a central site of action, bremazocine activates renal mechanisms to regulate water and electrolytes metabolism. The complexity of the pharmacology of opiates in the regulation of urine output may be related to this dual mechanism.
dc.fuente.origenWOS
dc.identifier.eissn1521-0103
dc.identifier.issn0022-3565
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/99251
dc.identifier.wosidWOS:A1989AQ41100033
dc.issue.numero3
dc.language.isoen
dc.pagina.final999
dc.pagina.inicio992
dc.revistaJournal of pharmacology and experimental therapeutics
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleDIURETIC EFFECT OF BREMAZOCINE, A KAPPA-OPIOID WITH CENTRAL AND PERIPHERAL SITES OF ACTION
dc.typeartículo
dc.volumen250
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas